Default company panoramic image
Logo

Rotalactis s.r.l.

A proprietary peptide, derived from donkey's milk Lactadherin, for a natural vaccine-like prevention and treatment of Rotavirus infections

  • Stage Concept Only
  • Industry Biotechnology
  • Location Turin, Piedmont, Italy
  • Currency EUR
  • Founded December 2008
  • Employees 1
  • Website rotalactis.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.